Skip to main content

. 2013 May 20;7:85. doi: 10.4137/CMO.S11910

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

Takuya Araki ^1,^2,^✉, Hideaki Yashima ^1,², Kimihiro Shimizu ³, Tohru Aomori ^1,^2,⁴, Tadahiro Hashita ², Kyoichi Kaira ⁵, Tomonori Nakamura ^1,², Koujirou Yamamoto ^1,²

PMCID: PMC3667686

This article (Clinical Medicine Insights: Oncology. 2012;6:407–21. doi: 10.4137/CMO.S7340) is corrected at the request of the original authors. Table 2 contains an error.

The table compares gefitinib to placebo in the INTEREST trial. In this trial, gefitinib was compared to Docetaxel and not placebo.

ACTIONS

RESOURCES